Bounded definition
The cited prime-editing study reports target- and condition-specific intended edits and byproducts using specified sequencing assays. Within this page, that proposition is limited to The constructs, biological systems, protocols, assays, datasets, and comparisons reported in Search-and-replace genome editing without double-strand breaks or donor DNA.
Definition and evidence boundary
Joint measurement of intended sequence outcomes, indels, partial edits, bystanders, and other products in a defined sample. The bounded proposition retained by the canonical record is: The cited prime-editing study reports target- and condition-specific intended edits and byproducts using specified sequencing assays.
The applicable scope is The constructs, biological systems, protocols, assays, datasets, and comparisons reported in Search-and-replace genome editing without double-strand breaks or donor DNA. This definition must not be generalized beyond the cited source and exact record boundary.
Claims: urn:maha:claim:editing-efficiency-and-byproduct-measurement
Mechanism and technical context
The study introduces a Cas9 nickase–reverse-transcriptase editor and prime-editing guide RNA architecture and reports specified edit classes in named cell systems. This is the source-bound technical context for the record; no uncited mechanism is added by the compiler.
A headline efficiency without denominator, assay, detection threshold, byproduct taxonomy, biological replicate, and cell context is not portable. The mechanism or method is therefore presented as one component of a larger system, not as evidence for every downstream outcome.
Claims: urn:maha:claim:editing-efficiency-and-byproduct-measurement
How to interpret the evidence
There is no universal effect estimate for this method; numerical results remain attached to the source experiment, biological system, assay, and analysis choices. The evidence maturity recorded here is single study, and the claim kind is empirical claim.
This candidate records one bounded source package. Independent replications and contradictory results must be compiled separately before evidence maturity is upgraded. The study does not establish general delivery, organism-level safety, clinical benefit, or universal editing efficiency. These qualifications travel with the claim whenever it is reused.
Claims: urn:maha:claim:editing-efficiency-and-byproduct-measurement
What the source supports and what remains unknown
The inspected source supports exactly this: The study introduces a Cas9 nickase–reverse-transcriptase editor and prime-editing guide RNA architecture and reports specified edit classes in named cell systems. It was read at Abstract; Figures 1–5; Methods; Extended Data; Supplementary Tables 1–5.
What remains unknown is everything outside that locator. A headline efficiency without denominator, assay, detection threshold, byproduct taxonomy, biological replicate, and cell context is not portable. No quantity, comparison, or downstream outcome is established here unless a separately scoped record measures it.
Claims: urn:maha:claim:editing-efficiency-and-byproduct-measurement
Source identity, locator, and reuse boundary
The bound source is “Search-and-replace genome editing without double-strand breaks or donor DNA” by Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, et al., published by Nature on 2019-10-21; its declared stable identity is doi:10.1038/s41586-019-1711-4.
The inspected-content locator is Abstract; Figures 1–5; Methods; Extended Data; Supplementary Tables 1–5. Reuse is limited to citation-with-paraphrase. Maha paraphrases the source-level result and links to the version of record; no article passage is reproduced. This metadata establishes source identity and inspection scope, not the truth of claims outside the cited locator.
Claims: urn:maha:claim:editing-efficiency-and-byproduct-measurement
Comparison and calculation boundary
Applicability is decided explicitly, not filled with generic material.
This record carries 1 source-bound proposition and therefore has no second supported side. A comparison would have to be manufactured from an adjacent title rather than from a second inspected claim, which the gate forbids.
The canonical claim declares no reproducible numerical inputs, equation, units, or uncertainty propagation; recorded uncertainty kind is qualitative. Supplying sample values would invent an unsupported quantitative result.
Limitations and prohibited inference
The claim stops where its evidence stops.
- record boundary
A headline efficiency without denominator, assay, detection threshold, byproduct taxonomy, biological replicate, and cell context is not portable.
- record boundary
A source-bounded mechanism, method, or measurement record does not establish manufacturing yield, economic advantage, safety, clinical benefit, or commercial readiness unless those outcomes are measured in a separately scoped record.
- prohibited inference
Do not treat the editing efficiency and byproduct measurement record as medical advice, a treatment recommendation, or evidence of general clinical readiness.
- prohibited inference
Do not transfer a reported result across hardware, organisms, protocols, datasets, operating conditions, or outcome definitions without a declared comparison contract.
- editorial
This compilation reorganizes an existing inspected claim and its declared source; it does not add a new experiment, measurement, or independent replication.
- editorial
Internal editorial inspection is not external peer review, and no result on this page has been independently reproduced.
Related records and mathematical bridges
Typed links expose context without asserting equivalence.
Adenine base editing
Declared mechanistic-dependency edge into this record, so it is positioned earlier in the same bounded sequence.
Selection: bridge edge
Cytosine base editing
Declared mechanistic-dependency edge into this record, so it is positioned earlier in the same bounded sequence.
Selection: bridge edge
Double-strand-break repair outcomes
Declared mechanistic-dependency edge into this record, so it is positioned earlier in the same bounded sequence.
Selection: bridge edge
Prime editing
Declared mechanistic-dependency edge from this record. The edge is navigational and asserts no equivalence or causation beyond the cited source scope.
Selection: bridge edge
Targeted amplicon sequencing of edit outcomes
Declared mechanistic-dependency edge from this record. The edge is navigational and asserts no equivalence or causation beyond the cited source scope.
Selection: bridge edge
When no declared bridge edge is present, related records are linked by shared evidence or canonical domain adjacency. Those links are navigational and do not claim mathematical or physical equivalence.
Connected domain graph
Typed dependencies preserve publication state.
Only independently canonical records receive public links and relation statements. Draft graph topology remains private.
Double-strand-break repair outcomes
inbound connection · mechanism
Repair products require direct target-level measurement.
Cytosine base editing
inbound connection · concept
Base-editing claims require joint measurement of intended products and byproducts.
Adenine base editing
inbound connection · concept
Targeted products and byproducts require experiment-level measurement.
Targeted amplicon sequencing of edit outcomes
inbound connection · measurement
Targeted sequencing supplies one measurement channel for intended products and local byproducts.
Prime editing
outbound connection · concept
Prime-editing performance is an empirical distribution of products, not one method-wide percentage.
Targeted amplicon sequencing of edit outcomes
outbound connection · measurement
Targeted sequencing is one method used to resolve the product distribution.
Claim ledger
Every proposition keeps its own evidence state.
The cited prime-editing study reports target- and condition-specific intended edits and byproducts using specified sequencing assays.
- Scope
- The constructs, biological systems, protocols, assays, datasets, and comparisons reported in Search-and-replace genome editing without double-strand breaks or donor DNA.
- Boundary
- A headline efficiency without denominator, assay, detection threshold, byproduct taxonomy, biological replicate, and cell context is not portable.
- Uncertainty
- There is no universal effect estimate for this method; numerical results remain attached to the source experiment, biological system, assay, and analysis choices.
- Replication
- This candidate records one bounded source package. Independent replications and contradictory results must be compiled separately before evidence maturity is upgraded.
Primary sources
Citation, locator, rights, and boundary travel together.
Source 1 · Nature
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, et al.
- Exact locator
- Abstract; Figures 1–5; Methods; Extended Data; Supplementary Tables 1–5.
- Establishes
- The study introduces a Cas9 nickase–reverse-transcriptase editor and prime-editing guide RNA architecture and reports specified edit classes in named cell systems.
- Boundary
- The study does not establish general delivery, organism-level safety, clinical benefit, or universal editing efficiency.
- Rights basis
- citation with paraphrase · Maha paraphrases the source-level result and links to the version of record; no article passage is reproduced.
- Declared interests
- The article declares patent applications and company relationships involving genome editing.